nitrendipine has been researched along with Hyperparathyroidism in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " (Ca+Mg)ATPase activity and passive Sr influx were measured to assess the rate of passive Ca influx (total and inhibited by dihydropyridines [DHPs]), in erythrocytes from patients with primary hyperparathyroidism and normal controls." | 3.69 | Erythrocyte membrane calcium transport in patients with primary hyperparathyroidism. ( Azzani, T; Bianchi, G; Casirati, P; Cusi, D; Muirhead, R; Reina, MC; Soldati, L; Vezzoli, G, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vezzoli, G | 1 |
| Reina, MC | 1 |
| Cusi, D | 1 |
| Casirati, P | 1 |
| Soldati, L | 1 |
| Azzani, T | 1 |
| Muirhead, R | 1 |
| Bianchi, G | 1 |
1 other study available for nitrendipine and Hyperparathyroidism
| Article | Year |
|---|---|
Erythrocyte membrane calcium transport in patients with primary hyperparathyroidism.
Topics: Biological Transport; Ca(2+) Mg(2+)-ATPase; Calcium; Dihydropyridines; Erythrocyte Membrane; Female; | 1994 |